Financhill
Sell
24

LITE Quote, Financials, Valuation and Earnings

Last price:
$67.20
Seasonality move :
-0.54%
Day range:
$65.21 - $69.61
52-week range:
$38.29 - $104.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.18x
P/B ratio:
5.23x
Volume:
4.7M
Avg. volume:
3M
1-year change:
44.39%
Market cap:
$4.6B
Revenue:
$1.4B
EPS (TTM):
-$7.69

Analysts' Opinion

  • Consensus Rating
    Lumentum Holdings has received a consensus rating of Buy. The company's average rating is a Buy based on 6 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $99.69, Lumentum Holdings has an estimated upside of 51.32% from its current price of $67.17.
  • Price Target Downside
    According to analysts, the lowest downside price target is $70.00 representing 100% downside risk from its current price of $67.17.

Fair Value

  • According to the consensus of 10 analysts, Lumentum Holdings has 51.32% upside to fair value with a price target of $99.69 per share.

LITE vs. S&P 500

  • Over the past 5 trading days, Lumentum Holdings has overperformed the S&P 500 by 4.75% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Lumentum Holdings does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Lumentum Holdings has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Lumentum Holdings reported revenues of $402.2M.

Earnings Growth

  • Lumentum Holdings has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Lumentum Holdings reported earnings per share of -$0.88.
Enterprise value:
6.2B
EV / Invested capital:
1.81x
Price / LTM sales:
3.18x
EV / EBIT:
--
EV / Revenue:
4.41x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
-92.89x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$288.3M
Return On Assets:
-12.61%
Net Income Margin (TTM):
-36.98%
Return On Equity:
-50.46%
Return On Invested Capital:
-14.4%
Operating Margin:
-12.66%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $1.8B $1.4B $1.4B $366.8M $402.2M
Gross Profit $716.3M $342.3M $288.3M $64M $99.6M
Operating Income $116.9M -$271.6M -$315.8M -$99.4M -$50.9M
EBITDA $324.1M $31M -$27.1M -$27M $28.2M
Diluted EPS $0.37 -$3.94 -$7.69 -$1.47 -$0.88
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $2.3B $2.5B $2.5B $2.1B $1.7B
Total Assets $3.5B $3.6B $4.4B $4.7B $4B
Current Liabilities $647.3M $656.7M $814.3M $658.4M $346.9M
Total Liabilities $1.5B $1.6B $2.9B $3.4B $3.1B
Total Equity $1.9B $2B $1.5B $1.3B $872.3M
Total Debt $1.1B $1.2B $2.3B $2.8B $2.6B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations $306.6M $60.3M $92.4M -$1.5M $24.3M
Cash From Investing -$631.6M -$500M $185M -$394.9M -$30.7M
Cash From Financing $365.1M $316.9M -$267M $4.1M -$3.1M
Free Cash Flow $196.6M -$97.2M -$67.1M -$32.5M -$15.9M
LITE
Sector
Market Cap
$4.6B
$91.6M
Price % of 52-Week High
63.35%
60%
Dividend Yield
0%
0%
Shareholder Yield
--
0.82%
1-Year Price Total Return
40.8%
-15.91%
Beta (5-Year)
1.034
0.910
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $64.18
200-day SMA
Buy
Level $67.05
Bollinger Bands (100)
Sell
Level 69.65 - 90.35
Chaikin Money Flow
Sell
Level -97.5M
20-day SMA
Sell
Level $68.14
Relative Strength Index (RSI14)
Sell
Level 46.52
ADX Line
Sell
Level 24.11
Williams %R
Neutral
Level -49.4136
50-day SMA
Sell
Level $79.04
MACD (12, 26)
Sell
Level -4.16
25-day Aroon Oscillator
Sell
Level -72
On Balance Volume
Neutral
Level 113.4M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.8182)
Sell
CA Score (Annual)
Level (-1.7881)
Buy
Beneish M-Score (Annual)
Level (-2.7661)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (1.1675)
Buy
Piotroski F Score (Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.

Stock Forecast FAQ

In the current month, LITE has received 6 Buy ratings 4 Hold ratings, and 0 Sell ratings. The LITE average analyst price target in the past 3 months is $99.69.

  • Where Will Lumentum Holdings Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Lumentum Holdings share price will rise to $99.69 per share over the next 12 months.

  • What Do Analysts Say About Lumentum Holdings?

    Analysts are divided on their view about Lumentum Holdings share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Lumentum Holdings is a Sell and believe this share price will drop from its current level to $70.00.

  • What Is Lumentum Holdings's Price Target?

    The price target for Lumentum Holdings over the next 1-year time period is forecast to be $99.69 according to 10 Wall Street analysts, 6 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is LITE A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Lumentum Holdings is a Buy. 6 of 10 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of LITE?

    You can purchase shares of Lumentum Holdings via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Lumentum Holdings shares.

  • What Is The Lumentum Holdings Share Price Today?

    Lumentum Holdings was last trading at $67.20 per share. This represents the most recent stock quote for Lumentum Holdings. Yesterday, Lumentum Holdings closed at $67.17 per share.

  • How To Buy Lumentum Holdings Stock Online?

    In order to purchase Lumentum Holdings stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
50
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
52
RGC alert for Mar 20

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Buy
82
EXOD alert for Mar 20

Exodus Movement [EXOD] is up 35.1% over the past day.

Sell
49
SRPT alert for Mar 20

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock